We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+25.52%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.53B
AUM Growth
+$1.89B
Cap. Flow
+$270M
Cap. Flow %
2.83%
Top 10 Hldgs %
11.36%
Holding
417
New
23
Increased
169
Reduced
161
Closed
41

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$39.8M
2
DAVA icon
Endava
DAVA
+$35.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$32.6M
4
HALO icon
Halozyme
HALO
+$30.3M
5
AZTA icon
Azenta
AZTA
+$29M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$67.2M
2
VRTU
Virtusa Corporation
VRTU
+$45.8M
3
SITE icon
SiteOne Landscape Supply
SITE
+$40.6M
4
PODD icon
Insulet
PODD
+$37.5M
5
FIVE icon
Five Below
FIVE
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 15.98%
3 Industrials 14.75%
4 Consumer Discretionary 13.32%
5 Financials 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VXF icon
351
Vanguard Extended Market ETF
VXF
$32.1B
$30K ﹤0.01%
183
-2
-1% -$296
TLK icon
352
Telkom Indonesia
TLK
$14.4B
$28K ﹤0.01%
1,200
+75
+7% +$1.58K
QDEL icon
353
QuidelOrtho
QDEL
$1.02B
$27K ﹤0.01%
152
-302,183
-100% -$67.2M
ABEV icon
354
Ambev
ABEV
$43.5B
$23K ﹤0.01%
7,435
+505
+7% +$1.36K
CSGP icon
355
CoStar Group
CSGP
$12.4B
$18K ﹤0.01%
200
– –
EVR icon
356
Evercore
EVR
$11.5B
$14K ﹤0.01%
131
– –
IAA
357
DELISTED
IAA, Inc. Common Stock
IAA
$14K ﹤0.01%
215
– –
VRTU
358
DELISTED
Virtusa Corporation
VRTU
$13K ﹤0.01%
265
-911,783
-100% -$45.8M
JBTM
359
JBT Marel
JBTM
$6.15B
$11K ﹤0.01%
99
-61,771
-100% -$6.37M
LKQ icon
360
LKQ Corp
LKQ
$6.25B
$10K ﹤0.01%
285
– –
WAB icon
361
Wabtec
WAB
$49.9B
$10K ﹤0.01%
139
– –
SIVB
362
DELISTED
SVB Financial Group
SIVB
$10K ﹤0.01%
26
– –
VB icon
363
Vanguard Morningstar Small-Cap ETF
VB
$83B
$9K ﹤0.01%
+46
New +$8.12K
LECO icon
364
Lincoln Electric
LECO
$15.6B
$8K ﹤0.01%
70
– –
ECPG icon
365
Encore Capital Group
ECPG
$2.07B
$7K ﹤0.01%
190
-127,116
-100% -$4.62M
GSK icon
366
GSK
GSK
$101B
$7K ﹤0.01%
152
-80
-34% -$3.67K
WBS icon
367
Webster Financial
WBS
$12.8B
$7K ﹤0.01%
158
-398,642
-100% -$14.4M
GBT
368
DELISTED
Global Blood Therapeutics, Inc.
GBT
$6K ﹤0.01%
142
-92,174
-100% -$4.54M
PINC
369
DELISTED
Premier
PINC
$3K ﹤0.01%
75
– –
WDFC icon
370
WD-40
WDFC
$3.12B
$3K ﹤0.01%
10
-33
-77% -$7.99K
BERY
371
DELISTED
Berry Global Group, Inc.
BERY
$3K ﹤0.01%
49
– –
BJRI icon
372
BJ's Restaurants
BJRI
$1.48B
$2K ﹤0.01%
45
– –
MIDD icon
373
Middleby
MIDD
$5.38B
$2K ﹤0.01%
15
– –
LEN icon
374
Lennar Class A
LEN
$20.5B
$1K ﹤0.01%
7
– –
MIK
375
DELISTED
Michaels Stores, Inc
MIK
$1K ﹤0.01%
80
– –
13 14
15
16 17

Similar funds

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

GW&K Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, GW&K Investment Management held 417 positions worth $9.53B, up 25% from $7.64B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q4 2020 filing shows 23 new, 169 increased, 161 reduced and 41 closed positions. Its largest new stake was Medpace: 315,843 shares worth $44M. The largest sale was QuidelOrtho, an estimated $67.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • GW&K Investment Management's largest Q4 2020 buy was Medpace: 315,843 shares worth $44M.
  • GW&K Investment Management added most to Endava in Q4 2020, an estimated $35.7M increase.
  • GW&K Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $67.2M.
  • GW&K Investment Management fully exited Aimmune Therapeutics in Q4 2020, selling an estimated $10.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $9.53B portfolio in Q4 2020.
  • GW&K Investment Management opened 23 new positions and closed 41 in Q4 2020.
  • GW&K Investment Management's portfolio value rose 25% quarter-over-quarter to $9.53B.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.